SEC Form 4 · accession 0001144204-16-093681
PALISADE BIO, INC. · PALI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jones Jonathan Brian Lloyd
Officer — Chief Financial Officer
Period of report
Mar 8, 2016
Accepted (ET)
Apr 11, 2016 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001357459
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Purchase OptionF1 | $0.94 | Mar 8, 2016 | A | 79,776 | A | Mar 8, 2016 | Mar 8, 2026 | Common Stock | 79,776 | 79,776 | D |
Explanation of responses
- F1Represents long term incentive bonus. The options vest quarterly over three years commencing on 3/8/2016.
Remarks
Exhibit 24 - Power of Attorney.